BCL2L1 and cancer: We further compared the relative expression of these molecules in 14 cancer types containing paired tumor and normal samples and found that approximately half of the autophagy regulators showed elevated expression in different cancers, including BIRC5, RIPK2, MET, ITGA6, BCL2L1, CASP4, etc. (Fig. 1 C).